These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10264040)

  • 1. Competition is driving down prices of many high-volume pharmaceuticals.
    Kuntz EF
    Mod Healthc; 1983 Dec; 13(12):60-2. PubMed ID: 10264040
    [No Abstract]   [Full Text] [Related]  

  • 2. Generics, private-labels may shake stagnant cephalosporin prices.
    Brightbill TC
    Hosp Mater Manage; 1987 Jun; 12(6):3-7. PubMed ID: 10283111
    [No Abstract]   [Full Text] [Related]  

  • 3. Cephalosporin prices rising in wake of Pryor bill.
    Barlow RD
    Hosp Mater Manage; 1991 Jul; 16(7):1, 12-3. PubMed ID: 10112311
    [No Abstract]   [Full Text] [Related]  

  • 4. Lawful uses of drugs purchased at preferential prices.
    Szeinbach SL; Fink JL
    Hosp Pharm; 1985 Jan; 20(1):24-8. PubMed ID: 10269764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMM drug price index advances at 4% annual rate.
    Hosp Mater Manage; 1987 Nov; 12(11):14-5. PubMed ID: 10285402
    [No Abstract]   [Full Text] [Related]  

  • 6. Vendor competition, generic drugs spur drop in pharmaceutical prices.
    Seigner CA
    Mod Healthc; 1985 Oct; 15(21):56, 60-2. PubMed ID: 10317662
    [No Abstract]   [Full Text] [Related]  

  • 7. Economics of hospital pharmacy practice. I. Third-party reimbursement.
    Zellmer WA
    Am J Hosp Pharm; 1979 Feb; 36(2):169. PubMed ID: 420204
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential pricing of pharmaceuticals and retail competition under the Robinson-Patman Act.
    Abood RR
    Am J Law Med; 1985; 11(3):293-317. PubMed ID: 3842232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. It is time to examine the prices you are charging for drugs.
    Davis NM
    Hosp Pharm; 1987 Nov; 22(11):1096, 1098, 1100. PubMed ID: 10284959
    [No Abstract]   [Full Text] [Related]  

  • 10. The strategic response by pharmaceutical firms to the Medicaid most-favored-customer rules.
    Scott Morton F
    Rand J Econ; 1997; 28(2):269-90. PubMed ID: 11794358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacy Benefit Managers, Brand-Name Drug Prices, and Patient Cost Sharing.
    Bai G; Sen AP; Anderson GF
    Ann Intern Med; 2018 Mar; 168(6):436-437. PubMed ID: 29435565
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence and response to the impact of the Medicaid Drug Rebate Program (OBRA) on hospital pharmacy: a progress report from central Ohio.
    Taylor S; Kucukarslan S; Sherrin T
    Hosp Pharm; 1991 Jul; 26(7):621, 624-5. PubMed ID: 10111796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do pharmaceutical prices respond to potential patient out-of-pocket expenses?
    Pavenik N
    Rand J Econ; 2002; 33(3):469-87. PubMed ID: 12585303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No surprises: brand-name prices up 4% while antibiotic and penicillin indexes fall.
    Hosp Mater Manage; 1988 Jun; 13(6):11. PubMed ID: 10318084
    [No Abstract]   [Full Text] [Related]  

  • 15. The differences in costs to hospitals and prices to patients for pharmaceutical products and services.
    Gillies RW; Winship HW
    Hosp Formul; 1976 Apr; 11(4):189-91, 195-8. PubMed ID: 1026683
    [No Abstract]   [Full Text] [Related]  

  • 16. Economics of hospital pharmacy practice. II: charging for services.
    Zellmer WA
    Am J Hosp Pharm; 1979 Mar; 36(3):307-8. PubMed ID: 420222
    [No Abstract]   [Full Text] [Related]  

  • 17. Three pharmacy indexes rise in 4th quarter.
    Hosp Mater Manage; 1989 Apr; 14(4):14. PubMed ID: 10292834
    [No Abstract]   [Full Text] [Related]  

  • 18. Competition of high-priced new drugs holds down prices of older drugs.
    Hosp Purch Manage; 1982 May; 7(5):14-5. PubMed ID: 10255154
    [No Abstract]   [Full Text] [Related]  

  • 19. A fee for the service of pharmacy: the time has come.
    Tanner DJ
    Hosp Pharm; 1978 Dec; 13(12):692-3, 696. PubMed ID: 10239821
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug prices come to life.
    Hosp Purch Manage; 1980 May; 5(5):18-9. PubMed ID: 10316963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.